TYROBP and neoplasm: As shown by previous animal studies, when the mice underwent TYROBP knockout, NKG2D, a DAP12-dependent NK cell receptor, was found to affect the antitumoral activity and modulate NK cell function, thus mainly engaging in the recognition and elimination of tumor cells [16].